Inventor · disambiguated record
Anup Barde
Also filed as: BARDE ANUP · BARDE ANUP RAMKRISHNA
8 granted patents·4 pending applications·18 citations·filing 2002–2024
80Inventor score
Top patents by PatentIndex Score
12 records- 0192US11584756B2Heterocyclic compounds as BET inhibitorsNUVATION BIO INC·Filed 2020·Granted Feb 21, 2023·3 cites·31 claims
- 0290US11826430B2Anti-cancer nuclear hormone receptor-targeting compoundsNUVATION BIO INC·Filed 2020·Granted Nov 28, 2023·2 cites·8 claims
- 0390US11292782B2Diarylhydantoin compounds and methods of use thereofNUVATION BIO INC·Filed 2019·Granted Apr 5, 2022·6 cites·39 claims
- 0490US11034669B2Pyrrole and pyrazole compounds and methods of use thereofNUVATION BIO INC·Filed 2019·Granted Jun 15, 2021·6 cites·16 claims
- 0580US12208141B2Anti-cancer nuclear hormone receptor-targeting compoundsNUVATION BIO INC·Filed 2023·Granted Jan 28, 2025·0 cites·19 claims
- 0678US2025276978A1Heterocyclic compounds as bet inhibitorsNUVATION BIO INC·Filed 2024·Application pending·0 cites
- 0773US2023339964A1Heterocyclic compounds as bet inhibitorsNUVATION BIO INC·Filed 2023·Application pending·0 cites
- 0868US12398121B2Anti-cancer nuclear hormone receptor-targeting compoundsNUVATION BIO INC·Filed 2022·Granted Aug 26, 2025·0 cites·12 claims
- 0965US2022213122A1Substituted 1,6-dihydropyridinones and 1,2-dihydroisoquinolinones as bet inhibitorsNUVATION BIO INC·Filed 2021·Application pending·0 cites
- 1062US11192900B2Substituted 1,6-dihydropyridinones and 1,2-dihydroisoquinolinones as bet inhibitorsNUVATION BIO INC·Filed 2019·Granted Dec 7, 2021·0 cites·25 claims
- 1161US2019375732A1Anti-cancer nuclear hormone receptor-targeting compoundsHUNG DAVID·Filed 2019·Application pending·0 cites
- 1244US6812363B2Racemization of optically active 2-substituted phenyl glycine estersUSV LTD·Filed 2002·Granted Nov 2, 2004·1 cites·6 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →